Your kid from the wrong side of the tracks wanted to be a lawyer? Tough luck now. Enrollment from first-gen grads is cratering, and it's all thanks to that Supreme Court gut-punch on affirmative action.
Amazon's dropping $50 billion on OpenAI—right after $8 billion into Anthropic. AWS boss Matt Garman calls it business as usual. But is it?
No congressional hearings, but D.C.'s think tanks are buzzing with AI-China showdowns and cyber warnings. Here's why these off-Congress chats could rewrite U.S. tech policy.
Picture this: your face deepfaked into a scam video, job lost to biased AI hiring. EU AI Act sounds protective—until you hunt for fixes. It points elsewhere.
Eli Lilly isn't mincing words: Amgen's patents are toast under §112. With SCOTUS oral arguments looming, the biotech world holds its breath.
You're staring at a 'patent pending' sticker, popping champagne. Then reality hits: without killer claims, your invention's toast. Here's why drafting them right now matters—before the USPTO laughs you out.
Imagine cops bringing a drug dog right up to your apartment door—no warrant needed. That's the fight heading to the Supreme Court, pitting urban renters' privacy against police tactics.
Imagine defending your patent without the endless IPR gauntlet. USPTO's latest stats show institutions down 43%, handing real wins to innovators buried in PTAB backlog.
Judges O'Malley and Chen just handed the PTAB a rare rebuke in SIPCO v. Emerson, flipping the script on covered business method reviews. It's not just a win for vending machine tech—it's a blueprint for dodging Section 101 traps.
Picture this: Samsung, bleeding $420 million from patent verdicts, fires back with antitrust nukes at Netlist. But the DOJ? It just strolled in, cool as ice, and said hold up—not so fast.
Imagine patenting a blockbuster drug — only to find the AI's creators knocking for their share. That's the hidden trap in today's AI boom.
Patent pros from the US and Europe train worlds apart—yet blending them crafts unbreakable global portfolios. Here's the how and why behind this tactical shift.
Small inventors betting on the STRONGER Patents Act might find their patents safer from IPR attacks—or ensnared in legal gray zones. Vague rules on 'validity decisions' could let trolls thrive while genuine innovators wait.
